OBJECTIVE: To compare the incidence of subsequent cancers in a cohort of patients with primary Sjögren's syndrome (pSS) with that of the general population in the same region of England. METHODS: A retrospective analysis was carried out on 112 patients who had attended the out-patients department at University College Hospital, London, from 1979 onwards. Patients were followed up from diagnosis of pSS to diagnosis of first subsequent cancer, death, loss to follow-up or 31 December 2003 (the censoring date) to determine the person-years at risk for each individual. The expected numbers of subsequent cancers were calculated from sex-/age-/period-specific rates for the general population of southeast England, derived from registrations at the ...
Background: Most literature on second primary cancers (SPCs) focuses on possible factors, which may ...
Patients with primary Sjögren’s syndrome (pSS) are at increased risk of developing malignant lymphom...
The objective of this study was to identify all malignancies in an inception cohort of SLE patients ...
Objectives: To assess the risk of lymphoproliferative disease or other malignancy (standardised inci...
International audienceThe relationship between cancer and primary Sjögren's syndrome (pSS) is uncert...
The purpose of this study is to characterize the risk of cancer in a large cohort of patients with p...
Abstract Background The purpose of this study is to characterize the risk of cancer in a large cohor...
OBJECTIVE: To assess the incidence of non-Hodgkin's lymphoma (NHL) and estimate the relative risk (R...
OBJECTIVE: In the 2016 American College of Rheumatology/European League Against Rheumatism classific...
Background : Primary Sjögren’s syndrome (pSS) is a chronic systemic autoimmune disease with an eleva...
OBJECTIVE: In the 2016 American College of Rheumatology/European League Against Rheumatism classific...
The aim of this study was to assess the prevalence of malignant lymphomas in patients with long-stan...
Studies of clinical series of psoriasis patients have suggested an increased risk of nonmelanoma ski...
Objective: In the 2016 American College of Rheumatology/European League Against Rheumatism classific...
Cancer occurrence in patients with multiple sclerosis (MS) has been little studied, but associations...
Background: Most literature on second primary cancers (SPCs) focuses on possible factors, which may ...
Patients with primary Sjögren’s syndrome (pSS) are at increased risk of developing malignant lymphom...
The objective of this study was to identify all malignancies in an inception cohort of SLE patients ...
Objectives: To assess the risk of lymphoproliferative disease or other malignancy (standardised inci...
International audienceThe relationship between cancer and primary Sjögren's syndrome (pSS) is uncert...
The purpose of this study is to characterize the risk of cancer in a large cohort of patients with p...
Abstract Background The purpose of this study is to characterize the risk of cancer in a large cohor...
OBJECTIVE: To assess the incidence of non-Hodgkin's lymphoma (NHL) and estimate the relative risk (R...
OBJECTIVE: In the 2016 American College of Rheumatology/European League Against Rheumatism classific...
Background : Primary Sjögren’s syndrome (pSS) is a chronic systemic autoimmune disease with an eleva...
OBJECTIVE: In the 2016 American College of Rheumatology/European League Against Rheumatism classific...
The aim of this study was to assess the prevalence of malignant lymphomas in patients with long-stan...
Studies of clinical series of psoriasis patients have suggested an increased risk of nonmelanoma ski...
Objective: In the 2016 American College of Rheumatology/European League Against Rheumatism classific...
Cancer occurrence in patients with multiple sclerosis (MS) has been little studied, but associations...
Background: Most literature on second primary cancers (SPCs) focuses on possible factors, which may ...
Patients with primary Sjögren’s syndrome (pSS) are at increased risk of developing malignant lymphom...
The objective of this study was to identify all malignancies in an inception cohort of SLE patients ...